BTG2 and familial pancreatic carcinoma: Several studies have reported that BTG2 expression is downregulated in some cancers, including laryngeal carcinoma (Liu et al., 2009), pancreatic cancer (Coppola et al., 2013) and renal cell carcinoma (Struckmann et al., 2004).